Literature DB >> 8460724

Commentary: the new female condom--item 1 on a women's AIDS prevention agenda.

E L Gollub1, Z A Stein.   

Abstract

A US Food and Drug Administration (FDA) advisory panel has recommended that the female condom Reality be approved for contraception and acquired immunodeficiency syndrome (AIDS) prevention. Final FDA approval will mark the first official recognition of a woman-controlled method for protection against sexually transmitted disease. A female condom allows women to use just one method to respond to the twin anxieties of AIDS and unwanted pregnancy. In those couples in which the man refuses to wear a male condom, the availability of a female condom makes protection possible for the first time. Although the female condom has some advantages over the male condom--greater comfort for some women and men and nonreliance on male arousal--general population experience with the device is needed to achieve regular widespread use and hence effectiveness at population levels. The FDA still lags behind in responding to women's needs for information on AIDS and sexually transmitted disease.

Entities:  

Mesh:

Year:  1993        PMID: 8460724      PMCID: PMC1694472          DOI: 10.2105/ajph.83.4.498

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  3 in total

1.  The double bind in science policy and the protection of women from HIV infection.

Authors:  Z A Stein
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

Review 2.  Family planning, sexually transmitted diseases and contraceptive choice: a literature update--Part I.

Authors:  W Cates; K M Stone
Journal:  Fam Plann Perspect       Date:  1992 Mar-Apr

3.  Commentary: methods women can use that may prevent sexually transmitted disease, including HIV.

Authors:  M J Rosenberg; E L Gollub
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

  3 in total
  14 in total

1.  Effect of an STD/HIV behavioral intervention on women's use of the female condom.

Authors:  Nancy Van Devanter; Virginia Gonzales; Cheryl Merzel; Nina S Parikh; David Celantano; Judith Greenberg
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

Review 2.  Female-initiated barrier methods for the prevention of STI/HIV: where are we now? Where should we go?

Authors:  M Latka
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

3.  Hispanic adults' beliefs, attitudes, and intentions regarding the female condom.

Authors:  L M Bogart; H Cecil; S D Pinkerton
Journal:  J Behav Med       Date:  2000-04

4.  Reducing HIV/AIDS transmission among African-American females: is the female condom a solution?

Authors:  Samatha Brown; Yolanda Wimberly
Journal:  J Natl Med Assoc       Date:  2005-10       Impact factor: 1.798

5.  Perspectives from the National Institute of Mental Health: Preventing or living with aids.

Authors:  E S Stover; W L Goldschmidts; L E Grau; L Mitnick; W Pequegnat; D M Rausch; B Vitiello
Journal:  Ann Behav Med       Date:  1996-03

6.  Two good reasons: women's and men's perspectives on dual contraceptive use.

Authors:  C Woodsong; H P Koo
Journal:  Soc Sci Med       Date:  1999-09       Impact factor: 4.634

Review 7.  More on women and the prevention of HIV infection.

Authors:  Z A Stein
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

Review 8.  Clinical aspects of HIV infection in women.

Authors:  G O Coodley; M K Coodley; A F Thompson
Journal:  J Gen Intern Med       Date:  1995-02       Impact factor: 5.128

9.  Female condom use among injection drug- and crack cocaine-using women.

Authors:  R S Ashery; R G Carlson; R S Falck; H A Siegal; J Wang
Journal:  Am J Public Health       Date:  1995-05       Impact factor: 9.308

10.  The risk of HIV infection in a national sample of women with injection drug-using partners.

Authors:  S Tortu; M Beardsley; S Deren; W R Davis
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.